The importance of colonoscopy quality assurance measures was properly embraced when the European Union in 2003 recommended organized colorectal cancer (CRC) screening programs in member states provided quality assurance monitoring at all levels of the service [1]. Independently, or in the wake of this, the first two colonoscopy quality assurance programs were launched in the United Kingdom and Norway in the autumn of 2003 [2, 3]. Many countries followed suit and convincing results, mostly from CRC screening studies, emerged. After some years, reduced interval cancer rates were found to be correlated with adenoma detection rates (ADR) and polypectomy [4,5].